Applied Filters
Bayer to spend up to $4bn on Asklepios BioPharmaceutical
Germany-based Bayer will pay up to $4 billion to acquire gene therapy company Asklepios BioPharmaceutical.
DNA start-up refused UK trademark
An Australian personalised genomics company has failed in its effort to obtain protection for its ‘MyDNA.life’ trademark in the UK.
Australian court rejects cattle genome patent appeal
The Federal Court of Australia has refused to block a cattle genome patent from the US, dismissing an appeal from Meat and Livestock Australia.
ERS Genomics appoints vice-president of IP
ERS Genomics, the company that provides access to CRISPR/Cas9 IP owned by researcher Emmanuelle Charpentier, has appointed Michael Arciero as vice-president of IP and commercial development.
Broad and ERS Genomics both claim victory in latest CRISPR ruling
The Broad Institute and ERS Genomics, a company that provides access to CRISPR/Cas9 IP owned by researcher Emmanuelle Charpentier, have both claimed victory in the latest round of the CRISPR inventorship battle.
BGI wins partial lifting of Illumina injunction
Beijing-based BGI Genomics can continue to develop its DNA sequencing technology pending an appeal in a patent dispute with Illumina, a US federal court has ruled.
KIPA hires former Decode Genetics director
IP boutique KIPA has strengthened its team with the addition of Iceland-based patent attorney Thorlakur Jonsson.
Fed Circuit orders new Bio-Rad trial, but upholds $24m award
The US Court of Appeals for the Federal Circuit has partially lifted an injunction on 10X Genomics, but the biotech company must still pay almost $24 million for infringing a Bio-Rad patent.
Personal Genomics takes PacBio dispute to Chinese court
Taiwanese biotechnology company Personal Genomics is using California’s Pacific Biosciences for patent infringement in China.
Natera and Illumina settle litigation, agree mutual licence
Natera has agreed to license Illumina IP covering non-invasive prenatal testing (NIPT), in a deal that sees the pair settle all outstanding patent litigation over the technology.
